(lp0
S'Keep An Eye On Rexahn Pharmaceuticals Inc  This Year Insider Financial - Mar 13, 2017 Rexahn Pharmaceuticals, Inc.  ran up towards the end of last week on basically no news, and is running again early session in the US on Monday.The Epic Rise of Rexahn Pharmaceuticals, Inc.  - The Oracle DispatchWhy Analysts put forward these two stocks: Rexahn Pharmaceuticals, Inc. (RNN ... - The USA Commerce'
p1
aS'Rexahn Pharmaceuticals  Jumps: Stock Moves Up 5.4% March 16, 2017 Zacks.com - Mar 16, 2017 Rexahn Pharmaceuticals, Inc.  was a big mover last session, as its shares rose above 5% on the day.'
p2
aS"Rexahn Pharmaceuticals, Inc.  Announces Full Year 2016 Financial Results Smarter Analyst - Feb 27, 2017 Rexahn Pharmaceuticals, Inc.  announced financial results for the year ended December 31, 2016 and provided an update on the Company's clinical development programs.Shares of Rexahn Pharmaceuticals, Inc.  Plunge -4.8% - Energy Index"
p3
aS"What are Analyst's Indicators for Catabasis Pharmaceuticals, Inc. (CATB ... The USA Commerce - Mar 13, 2017 Shares of Catabasis Pharmaceuticals, Inc.  surged 53.38% to $2.04. During the trading on 03/10/2017, Company's stock ranged from $1.58 to $2.76. The relative strength index or RSI highlights overbought  and oversold (below&nbsp;..."
p4
aS"Is It Time to go for Rexahn Pharmaceuticals, Inc. , TG Therapeutics, Inc ... StockNewsJournal - Mar 10, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.Rexahn Pharmaceuticals, Inc. : A Detailed Look at its Institutional Ownership - Post AnalystRexahn Pharmaceuticals, Inc.'s  stock price is Worth at $0.32 while ... - Hot Stocks Point"
p5
aS'Rexahn Pharmaceuticals, Inc.  Initiates Clinical Trial to Evaluate the ... Smarter Analyst - Feb 23, 2017 Rexahn Pharmaceuticals, Inc.  announced that is has begun enrolling patients into a Phase IIa clinical study of Supinoxin in metastatic triple negative breast cancer .'
p6
aS"Rexahn Pharmaceuticals, Inc.'s  stock price is Worth at $0.47 while ends ... Hot Stocks Point - 23 hours ago Rexahn Pharmaceuticals, Inc.  stock price ended its day with loss -2.60% and finalized at the price of $0.47. During its last trading session, Stock traded with the total exchanged volume of 4.2 million shares."
p7
aS'Rexahn Pharmaceuticals, Inc.  Is Trying To Tell Investors Something ... NY Stock News - 22 hours ago The technicals for Rexahn Pharmaceuticals, Inc.  has spoken via its technical chart and the message is loud and clear.'
p8
aS"Most Active Stock Update: Rexahn Pharmaceuticals, Inc.  HugoPress - Mar 15, 2017 MLV &amp; Co. Initiates Coverage on Rexahn Pharmaceuticals, Inc. 's stock to Buy with the price target of $1.3."
p9
aS'The Technicals For Rexahn Pharmaceuticals, Inc.  Tell An Interesting Tale NY Stock News - Mar 14, 2017 The technicals for Rexahn Pharmaceuticals, Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p10
a.